Efficacy and Tolerability of AXA1125, an Endogenous Metabolic Modulator Composition, in Fatigue-predominant Long COVID: A Randomized, Double-blind, Placebo-controlled Study
Finnigan L., Cassar M., Koziel M., Azer K., Kirby D., Pradines J., Montgomery H., Neubauer S., Valkovic L., Raman B.